VCCC Alliance Precision Oncology Forum
Examining the spatial heterogeneity of high grade glioma
21 Jul 2023
High-grade gliomas are aggressive primary brain cancers with poor response to standard regimens, driven by immense heterogeneity.
…
21 Jul 2023
High-grade gliomas are aggressive primary brain cancers with poor response to standard regimens, driven by immense heterogeneity.
…
2 October 2023
Women with germline pathogenic variants in the BRCA1/2 genes are at increased lifetime risk of breast and ovarian cancer.
Australian guidelines were revised in 2013, now recommending genetic testing for all patients…
Collaborative Efforts in Pioneering Sarcoma Research and Enhancing Patient Access - Australia and New Zealand Sarcoma…
19 Sep 2023
Dr Sarah Dalton discusses the importance and role of professional coaching.
9 October 2023
A revolutionary new app, complete with disease-specific QR codes, is set to transform how patients from CALD backgrounds affected by cancer access information about their care. Hear Professor Justin Yeung and his team discuss the…
Wednesday 13 September
The VCCC Alliance Cancer Communities Forum is a no-holes-barred forum that is presented and led by leading cancer experts and consumers.
Targeted therapies have progressed in…
16th October 2023
A Research Statement from the American Society of Clinical Oncology (ASCO), released 2 October 2023 has outlined new recommendations for appropriate assessment of ovarian toxicity in cancer clinical trials.
Previously,…
The VCCC Alliance together with the Picchi Brothers Foundation celebrate the achievements of this year's three Picchi Awardees for Excellence in Cancer Research.
The VCCC…
23 October 2023
Evaluating how well new drugs work and any potential toxic side effects is essential to discovering new therapies – and gaining regulatory approval for use. In this webinar Dr Alastair J King dives into the world of database…
30 October 2023
The Suspected Cancer Pathway (SCP) is a Welsh Government target for diagnosing cancer and starting treatment more quickly. It also indicates where information and support should be provided to patients across the pathway.
…